| |
PROJECT OVERVIEW |
| |
|
Welcome to the Harvard Neuromuscular
Disease Project web site. This project aims to study gene
expression in normal and diseased muscle. The Program
Director and Principal Investigators have a long and productive
history defining the molecular genetics of human neuromuscular
diseases. With their strong backgrounds and notable breakthroughs,
they are collaborating on this project in anticipation
that the research will result in a better understanding
of the pathology of specific neuromuscular diseases and
in new approaches to the treatment of the muscular dystrophies
and myopathies. |
|
| |
|
|
|
|
 |
| |
OUR GOALS |
| |
|
There are several goals of
the Neuromuscular Disease Project, with the primary goal
of increasing the diagnostic and therapeutic abilities
related to neuromuscular disease. Click here to learn
more about our research and our goals. |
|
| |
|
|
|
|
|
| |
RESEARCHER
INFORMATION |
| |
|
To elucidate the similarities
and differences between various neuromuscular disorders,
we are using DNA microarray technology to identify the
changes that occur in gene expression in a group of muscular
dystrophies and myopathies. |
|
| |
|
|
|
|
| |
NEWS
& EVENTS |
| |
|
Visit our data
and publications page to view recent abstracts and
data sets.
We just added patient and physician/researcher brochures
to our web site. These can be downloaded in PDF format.
Louis Kunkel was honored as the Allan Award recipient at the American Society of Human Genetics Conference in Toronto, Canada in 2004. Jane Gitschier introduced Dr. Kunkel, who then discussed the parts of his career that he feels contributed the most to being the recipient of the award, including the cloning of the gene that causes Duchenne muscular dystrophy. To review the introductory speach and Dr. Kunkel's lecture, please use the following links. Introduction • Kunkel Lecture |
|
|
| |
|
|
|
|
|
| Our research
is performed in the Enders Building on the Children's
Hospital, Boston campus, in the Longwood Medical Area. |
 |
|
|
|
|
